|157.52||+2.91||+1.88%||Vol 971.08K||1Y Perf 42.91%|
|Jul 27th, 2021 15:05 DELAYED|
|8.15 5.27%||- -|
|Target Price||159.60||Analyst Rating||Moderate Buy 2.00|
|Potential %||1.31||Finscreener Ranking||★ 41.58|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★+ 45.67|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★+ 50.47|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||★ 30.44|
|Market Cap||13.43B||Earnings Rating||Buy|
|Price Range Ratio 52W %||88.59||Earnings Date||26th Jul 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||2.75|
|EPS Growth Next 5 Years %||6.50|
|Avg. Weekly Volume||595.34K|
|Avg. Monthly Volume||642.03K|
|Avg. Quarterly Volume||661.30K|
Universal Health Services Inc. (NYSE: UHS) stock closed at 154.61 per share at the end of the most recent trading day (a 1.27% change compared to the prior day closing price) with a volume of 840.96K shares and market capitalization of 13.43B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 89000 people. Universal Health Services Inc. CEO is Marc D. Miller.
The one-year performance of Universal Health Services Inc. stock is 42.91%, while year-to-date (YTD) performance is 12.44%. UHS stock has a five-year performance of 18.48%. Its 52-week range is between 99.47 and 165, which gives UHS stock a 52-week price range ratio of 88.59%
Universal Health Services Inc. currently has a PE ratio of 12.90, a price-to-book (PB) ratio of 2.00, a price-to-sale (PS) ratio of 1.34, a price to cashflow ratio of 6.80, a PEG ratio of 2.32, a ROA of 7.92%, a ROC of 10.73% and a ROE of 16.43%. The company’s profit margin is 8.49%, its EBITDA margin is 16.50%, and its revenue ttm is $9.01 Billion , which makes it $115.58 revenue per share.
Of the last four earnings reports from Universal Health Services Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.75 for the next earnings report. Universal Health Services Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for Universal Health Services Inc. is Moderate Buy (2), with a target price of $159.6, which is +1.31% compared to the current price. The earnings rating for Universal Health Services Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Universal Health Services Inc. has a dividend yield of 0.52% with a dividend per share of $0.80 and a payout ratio of 1.00%.
Universal Health Services Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 5.76, ATR14 : 3.75, CCI20 : 98.06, Chaikin Money Flow : 0.11, MACD : -0.03, Money Flow Index : 63.21, ROC : 2.83, RSI : 54.25, STOCH (14,3) : 81.62, STOCH RSI : 1.00, UO : 45.57, Williams %R : -18.38), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Universal Health Services Inc. in the last 12-months were: Alan B. Miller (Sold 0 shares of value $-157 581 656 ), Eileen C. McDonnell (Sold 0 shares of value $-1 186 613 ), Eileen C. McDonnell (Sold 6 693 shares of value $1 010 815 ), Elliot J. Sussman (Sold 0 shares of value $-1 969 875 ), Elliot J. Sussman (Sold 2 553 shares of value $403 068 ), Lawrence S. Gibbs (Sold 0 shares of value $-2 018 700 ), Marc D. Miller (Sold 0 shares of value $-18 797 800 ), Marvin G. Pember (Sold 0 shares of value $-1 827 787 ), Steve G. Filton (Sold 0 shares of value $-9 151 700 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
This could take some time, please wait.